nicardipine has been researched along with Cephalgia, Vascular in 1 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
García-Alvarez, F | 1 |
Romero, MS | 1 |
al-Ghanem, R | 1 |
Calvo, MT | 1 |
Cortés, M | 1 |
Gutiérrez, M | 1 |
1 other study available for nicardipine and Cephalgia, Vascular
Article | Year |
---|---|
The increase in erythrocyte deformability in patients treated with nicardipine or nimodipine.
Topics: Administration, Oral; Adult; Aged; Erythrocyte Deformability; Female; Humans; Male; Middle Aged; Nic | 1993 |